|
US9963509B2
(en)
|
2014-12-23 |
2018-05-08 |
Full Spectrum Genetics, Inc. |
Anti-B7H3 binding compounds and uses thereof
|
|
US10865245B2
(en)
|
2014-12-23 |
2020-12-15 |
Full Spectrum Genetics, Inc. |
Anti-B7H3 binding compounds and uses thereof
|
|
WO2016207104A1
(de)
*
|
2015-06-23 |
2016-12-29 |
Bayer Pharma Aktiengesellschaft |
Antikörper-wirkstoff-konjugate (adcs) von ksp-inhibitoren mit anti-b7h3-antikörpern
|
|
US12128102B2
(en)
|
2016-03-08 |
2024-10-29 |
Takeda Pharmaceutical Company Limited |
Constrained conditionally activated binding proteins
|
|
US20190300606A1
(en)
*
|
2016-07-01 |
2019-10-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibitory Immune Receptor Inhibition Methods and Compositions
|
|
EP3571221A2
(en)
|
2017-01-20 |
2019-11-27 |
Juno Therapeutics GmbH |
Cell surface conjugates and related cell compositions and methods
|
|
CN109843927B
(zh)
*
|
2017-03-06 |
2022-06-21 |
江苏恒瑞医药股份有限公司 |
抗b7-h3抗体、其抗原结合片段及其医药用途
|
|
CA3056474A1
(en)
|
2017-03-31 |
2018-10-04 |
Jiangsu Hengrui Medicine Co., Ltd. |
B7-h3 antibody, antigen-binding fragment thereof and medical use thereof
|
|
MY200973A
(en)
|
2017-04-11 |
2024-01-26 |
Inhibrx Inc |
Multispecific Polypeptide Constructs Having Constrained Cd3 Binding And Methods Of Using The Same
|
|
JP2020520382A
(ja)
*
|
2017-05-12 |
2020-07-09 |
メモリアル スローン ケタリング キャンサー センター |
中枢神経系におけるがんを処置するための抗ｂ７ｈ３抗体の使用
|
|
TW201909926A
(zh)
*
|
2017-08-04 |
2019-03-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
Ｂ７ｈ３抗體－藥物偶聯物及其醫藥用途
|
|
WO2019032628A1
(en)
|
2017-08-07 |
2019-02-14 |
The Regents Of The University Of California |
GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
|
|
US11199371B2
(en)
|
2017-08-17 |
2021-12-14 |
Michael D. Miller |
Firearm assembly system and method
|
|
CN111356700A
(zh)
*
|
2017-09-08 |
2020-06-30 |
马弗里克治疗公司 |
受约束的条件性活化的结合蛋白
|
|
CN111278865B
(zh)
*
|
2017-10-26 |
2023-04-25 |
盛禾(中国)生物制药有限公司 |
新的重组融合蛋白及其制备和用途
|
|
CA3080835A1
(en)
|
2017-10-31 |
2019-05-09 |
Pantarhei Bioscience B.V. |
Immunotherapeutic methods for treating and/or preventing lung cancer
|
|
CN109939126A
(zh)
*
|
2017-12-21 |
2019-06-28 |
张曼 |
Cd3×b7h3双特异抗体定向杀伤耐阿霉素膀胱癌细胞pumc-91/adm的应用
|
|
CN109939231A
(zh)
*
|
2017-12-21 |
2019-06-28 |
张曼 |
关于cd3×b7h3双特异性抗体定向杀伤膀胱癌细胞t24的应用
|
|
CA3084518A1
(en)
|
2018-01-15 |
2019-07-18 |
Nanjing Legend Biotech Co., Ltd. |
Single-domain antibodies and variants thereof against pd-1
|
|
AU2019206207B2
(en)
*
|
2018-01-15 |
2025-04-10 |
Stichting Sanquin Bloedvoorziening |
Factor H potentiating antibodies and uses thereof
|
|
TW202010757A
(zh)
|
2018-04-11 |
2020-03-16 |
美商英伊布里克斯公司 |
具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途
|
|
WO2019225787A1
(ko)
*
|
2018-05-24 |
2019-11-28 |
에이비엘바이오 주식회사 |
항-b7-h3 항체 및 그 용도
|
|
WO2019241730A2
(en)
|
2018-06-15 |
2019-12-19 |
Flagship Pioneering Innovations V, Inc. |
Increasing immune activity through modulation of postcellular signaling factors
|
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
|
WO2020023553A1
(en)
|
2018-07-24 |
2020-01-30 |
Inhibrx, Inc. |
Multispecific polypeptide constructs containing a constrained cd3 binding domain and a receptor binding region and methods of using the same
|
|
US12274759B2
(en)
|
2018-08-23 |
2025-04-15 |
Regents Of The University Of Minnesota |
Affibody proteins specific for B7-H3 (CD276)
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
CN113166261A
(zh)
*
|
2018-10-11 |
2021-07-23 |
印希比股份有限公司 |
B7h3单域抗体及其治疗性组合物
|
|
EP3883970A4
(en)
*
|
2018-11-22 |
2022-03-30 |
Suzhou Kanova Biopharmaceutical Co., Ltd. |
ANTI-B7-H3 ANTIBODIES
|
|
EP4592313A3
(en)
|
2019-03-05 |
2025-11-19 |
Takeda Pharmaceutical Company Limited |
Constrained conditionally activated binding proteins
|
|
CN109929039A
(zh)
*
|
2019-03-28 |
2019-06-25 |
郑州大学第一附属医院 |
基于cd276抗体的嵌合抗原受体、慢病毒表达载体及其应用
|
|
MA55805A
(fr)
|
2019-05-03 |
2022-03-09 |
Flagship Pioneering Innovations V Inc |
Métodes de modulation de l'activité immunitaire
|
|
JP7137696B2
(ja)
|
2019-05-14 |
2022-09-14 |
プロヴェンション・バイオ・インコーポレイテッド |
１型糖尿病を予防するための方法および組成物
|
|
WO2020238926A1
(en)
*
|
2019-05-28 |
2020-12-03 |
Single Cell Technology, Inc. |
Anti-b7-h3 antibodies
|
|
CA3142634A1
(en)
*
|
2019-07-03 |
2021-01-07 |
Crystal Bioscience Inc. |
Anti-b7-h3 antibody and methods of use thereof
|
|
KR102732027B1
(ko)
*
|
2019-07-09 |
2024-11-20 |
주식회사 와이바이오로직스 |
B7-h3(cd276)에 특이적으로 결합하는 항체 및 그의 용도
|
|
JP7631296B2
(ja)
|
2019-07-17 |
2025-02-18 |
ジェミニ・セラピューティクス・サブ・インコーポレイテッド |
Ｈ因子増強性抗体及びその使用
|
|
EP4022313A1
(en)
|
2019-08-30 |
2022-07-06 |
Y-Mabs Therapeutics, Inc. |
Immunohistochemical assessment of b7-h3 expression
|
|
CN110642948B
(zh)
*
|
2019-10-09 |
2021-06-29 |
达石药业(广东)有限公司 |
B7-h3纳米抗体、其制备方法及用途
|
|
KR20220115572A
(ko)
|
2019-11-18 |
2022-08-17 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
항-b7-h3 단클론성 항체 및 이의 사용 방법
|
|
JP2023509359A
(ja)
|
2019-12-17 |
2023-03-08 |
フラグシップ パイオニアリング イノベーションズ ブイ，インコーポレーテッド |
鉄依存性細胞分解の誘導物質との併用抗癌療法
|
|
EP4097129A1
(en)
|
2020-01-29 |
2022-12-07 |
Inhibrx, Inc. |
Cd28 single domain antibodies and multivalent and multispecific constructs thereof
|
|
CN115916265A
(zh)
*
|
2020-04-24 |
2023-04-04 |
Y-单克隆抗体制药有限公司 |
带有螯合剂的b7h3抗体
|
|
WO2021244721A1
(en)
|
2020-06-04 |
2021-12-09 |
Y-Mabs Therapeutics, Inc. |
Anti-b7h3 antibodies for the treatment of cancer
|
|
KR20230092863A
(ko)
|
2020-06-11 |
2023-06-26 |
프로벤션 바이오, 인코포레이티드 |
제1형 당뇨병을 예방하기 위한 방법 및 조성물
|
|
CN116096906A
(zh)
|
2020-06-29 |
2023-05-09 |
旗舰创业创新五公司 |
工程化以促进萨诺传递的病毒及其在治疗癌症中的用途
|
|
CN111662384B
(zh)
*
|
2020-06-30 |
2021-04-09 |
广州百暨基因科技有限公司 |
抗b7h3抗体及其应用
|
|
TW202241935A
(zh)
|
2020-12-18 |
2022-11-01 |
美商世紀治療股份有限公司 |
具有可調適受體專一性之嵌合抗原受體系統
|
|
CA3203257A1
(en)
*
|
2020-12-23 |
2022-06-30 |
Li Li |
Anti-b7-h3 antibody and uses thereof
|
|
CN120093941A
(zh)
|
2021-02-09 |
2025-06-06 |
苏州宜联生物医药有限公司 |
生物活性物偶联物及其制备方法和用途
|
|
EP4313109A1
(en)
|
2021-03-31 |
2024-02-07 |
Flagship Pioneering Innovations V, Inc. |
Thanotransmission polypeptides and their use in treating cancer
|
|
MX2023013851A
(es)
|
2021-05-24 |
2023-12-08 |
Provention Bio Inc |
Metodos para el tratamiento de diabetes tipo 1.
|
|
US20240316104A1
(en)
|
2021-06-29 |
2024-09-26 |
Flagship Pioneering Innovations V, Inc. |
Immune cells engineered to promote thanotransmission and uses thereof
|
|
CN115558024A
(zh)
*
|
2021-07-02 |
2023-01-03 |
安源医药科技（上海）有限公司 |
抗b7-h3单克隆抗体及其用途
|
|
KR20240053668A
(ko)
*
|
2021-09-18 |
2024-04-24 |
스카이라인 테라퓨틱스 리미티드 |
Wet-AMD의 유전자 치료를 위한 AAV
|
|
CN118715242A
(zh)
*
|
2021-10-05 |
2024-09-27 |
得克萨斯州大学系统董事会 |
包含b7-h3结合多肽的组合物和方法
|
|
WO2023134716A1
(zh)
*
|
2022-01-14 |
2023-07-20 |
盛禾(中国)生物制药有限公司 |
一种结合b7h3和nkp30的双特异性抗体及其应用
|
|
EP4480499A1
(en)
|
2022-02-16 |
2024-12-25 |
Medilink Therapeutics (Suzhou) Co., Ltd. |
Conjugate of antibody-eribulin or derivative thereof, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and use thereof
|
|
CA3259975A1
(en)
|
2022-03-15 |
2023-09-21 |
Compugen Ltd. |
Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
|
|
CN116836281A
(zh)
*
|
2022-03-25 |
2023-10-03 |
英诺湖医药(杭州)有限公司 |
B7h3抗体及包含其的双功能抗体
|
|
IL316510A
(en)
*
|
2022-05-18 |
2024-12-01 |
Wuxi Biologics Ireland Ltd |
Anti-B7H3 antibody and its uses
|
|
EP4527415A1
(en)
|
2022-05-18 |
2025-03-26 |
Medilink Therapeutics (Suzhou) Co., Ltd. |
Antibody-drug conjugate containing protein degradation agent bioactive compound, method for preparing same, and use thereof
|
|
CN119768434A
(zh)
*
|
2022-08-19 |
2025-04-04 |
盛禾(中国)生物制药有限公司 |
一种双特异性抗体及其应用
|
|
WO2024077191A1
(en)
|
2022-10-05 |
2024-04-11 |
Flagship Pioneering Innovations V, Inc. |
Nucleic acid molecules encoding trif and additionalpolypeptides and their use in treating cancer
|
|
CN115819608A
(zh)
*
|
2022-10-08 |
2023-03-21 |
盛禾(中国)生物制药有限公司 |
一种纯化融合蛋白的方法
|
|
CN115845047A
(zh)
*
|
2022-11-07 |
2023-03-28 |
盛禾(中国)生物制药有限公司 |
一种异源二聚体蛋白质组合物
|
|
US20260201038A1
(en)
*
|
2022-11-15 |
2026-07-16 |
CellabMED Inc. |
Antibody specifically binding to b7-h3
|
|
WO2024151687A1
(en)
|
2023-01-09 |
2024-07-18 |
Flagship Pioneering Innovations V, Inc. |
Genetic switches and their use in treating cancer
|
|
TW202515608A
(zh)
|
2023-06-26 |
2025-04-16 |
以色列商坎布根有限公司 |
Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途
|
|
CN119454937A
(zh)
|
2023-11-13 |
2025-02-18 |
苏州宜联生物医药有限公司 |
抗b7h3抗体-药物偶联物治疗癌症的方法
|
|
WO2025129565A1
(zh)
*
|
2023-12-21 |
2025-06-26 |
西湖实验室(生命科学和生物医学浙江省实验室) |
一种cd276迷你结合蛋白及其突变体及应用
|
|
WO2025245264A1
(en)
*
|
2024-05-21 |
2025-11-27 |
Briapro Therapeutics Corp. |
Anti-b7-h3 antibodies and methods of use thereof
|